SEARCH

SEARCH BY CITATION

References

  • 1
    Pennebaker JW, Beall SK. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol 1986;95(3):274-281.
  • 2
    Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol 1998;66(1):174-184.
  • 3
    Frisina PG, Borod JC, Lepore SJ. A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis 2004;192(9):629-634.
  • 4
    Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull 2006;132(6):823-865.
  • 5
    Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Health Psychol 2004;23(6):555-563.
  • 6
    Graves KD, Schmidt JE, Bollmer F et al. Emotional expression and emotional recognition in breast cancer survivors: a controlled comparison. Psychol Health 2005;20(5):579-595.
  • 7
    Creswell JD, Lam S, Stanton AL, Taylor SE, Bower JE, Sherman DK. Does self-affirmation, cognitive processing, or discovery of meaning explain cancer-related health benefits of expressive writing? Pers Soc Psychol Bull 2007;33(2):238-250.
  • 8
    Low CA, Stanton AL, Bower JE, Gyllenhammer L. A randomized controlled trial of emotionally expressive writing for women with metastatic breast cancer. Health Psychol 2010;29(4):460-466.
  • 9
    Gellaitry G, Peters K, Bloomfield D, Horne R. Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer. Psycho-Oncology 2010;19(1):77-84.
  • 10
    Rosenberg HJ, Rosenberg SD, Ernstoff MS et al. Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 2002;32(1):37-53.
  • 11
    de Moor C, Sterner J, Hall M et al. A pilot study of the effects of expressive writing on psychological and behavioral adjustment in patients enrolled in a Phase II trial of vaccine therapy for metastatic renal cell carcinoma. Health Psychol 2002;21(6):615-619.
  • 12
    de Moor JS, Moye L, Low MD et al. Expressive writing as a presurgical stress management intervention for breast cancer patients. J Soc Integr Oncol 2008;6(2):59-66.
  • 13
    Cepeda MS, Chapman CR, Miranda N et al. Emotional disclosure through patient narrative may improve pain and well-being: results of a randomized controlled trial in patients with cancer pain. J Pain Symptom Manage 2008;35(6):623-631.
  • 14
    Low CA, Stanton AL, Danoff-Burg S. Expressive disclosure and benefit finding among breast cancer patients: mechanisms for positive health effects. Health Psychol 2006;25(2):181-189.
  • 15
    Walker BL, Nail LM, Croyle RT. Does emotional expression make a difference in reactions to breast cancer? Oncol Nurs Forum 1999;26(6):1025-1032.
  • 16
    Stanton AL, Danoff-Burg S, Sworowski LA, et al. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J Clin Oncol 2002;20(20):4160-4168.
  • 17
    Mosher CE, DuHamel KN, Lam J et al. Randomised trial of expressive writing for distressed metastatic breast cancer patients. Psychol Health 2012;27(1):88-100.
  • 18
    Craft MA, Davis GC, Paulson RM. Expressive writing in early breast cancer survivors. J Adv Nurs 2012 Apr 11. [E-pub ahead of print] DOI: 10.1111/j.1365-2648.2012.06008.x
  • 19
    Stroebe M, Stroebe S, Schut H, Zech E, van den Bout J. Does disclosure of emotions facilitate recovery from bereavement? Evidence from two prospective studies. J Consult Clin Psychol 2002;70(1):169-178.
  • 20
    Lepore SJ. A social-cognitive processing model of emotional adjustment to cancer. In Psychosocial Interventions for Cancer, Baum A, Andersen BL (eds). American Psychological Association: Washington D.C., 2001; 99-116.
  • 21
    Lepore SJ, Silver RC, Wortman CB, Wayment HA. Social constraints, intrusive thoughts, and depressive symptoms among bereaved mothers. J Pers Soc Psychol 1996;70(2):271-282.
  • 22
    Pennebaker JW. Opening Up: The Healing Power of Expressing Emotions. Guilford Press: New York, 1997.
  • 23
    Lumley MA, Tojek TM, Macklem DJ. Effects of written emotional disclosure among repressive and alexithymic people. In The Writing Cure — How Expressive Writing Promotes Health and Emotional Well-being, Lepore SJ, Smyth JM (eds). American Psychological Association: Washington, DC, 2002; 75-96.
  • 24
    Baikie KA. Who does expressive writing work for? Examination of alexithymia, splitting, and repressive coping style as moderators of the expressive writing paradigm. Br J Health Psychol 2008;13(Pt 1):61-66.
  • 25
    Christensen S, Zachariae R, Jensen AB et al. Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009;113(2):339-355.
  • 26
    Jensen AR, Storm HH, Moller S, Overgaard J. Validity and representativity in the Danish Breast Cancer Cooperative Group—a study on protocol allocation and data validity from one county to a multi-centre database. Acta Oncol 2003;42(3):179-185.
  • 27
    Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41:209-218.
  • 28
    Beck AT, Steer RA, Brown GK. Manual: Beck Depression Inventory (2nd edn). The Psychological Corporation. Hartcourt & Brace: San Antonio, TX, 1996.
  • 29
    Furlanetto LM, Mendlowicz MV, Bueno JR. The validity of the Beck Depression Inventory—Short Form as a screening and diagnostic instrument for moderate and severe depression in medical patients. J Affect Disord 2005;86:87-91.
  • 30
    Zevon MA, Tellegen A. The structure of mood change: an ideographic/nomothetic analysis. J Soc Pers Psychol 1982;43:111-122.
  • 31
    DiLorenzo TA, Bovbjerg DH, Montgomery GH, Valdimarsdottir H, Jacobsen PB. The application of a shortened version of the profile of mood states in a sample of breast cancer chemotherapy patients. Br J Health Psychol 1999;4:315-325.
  • 32
    Lepore SJ, Helgeson VS. Social constraints, intrusive thoughts, and mental health after prostate cancer. J Soc Clin Psychol 1998;17(1):89-106.
  • 33
    Bagby M, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia Scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994;38: 23-32.
  • 34
    O'Connor M, Christensen S, Jensen AB, Moller S, Zachariae R. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer 2011;104(3):419-426.
  • 35
    Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods 2002;7(2):147-177.
  • 36
    Tabachnick BG, Fidell LS. Using Multivariate Statistics (4th edn). Allyn & Bacon: Needham Heights, MA, 2007.
  • 37
    Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51(6):1173-1182.
  • 38
    Stanton AL, Danoff-Burg S. Emotional expression, expressive writing, and cancer. In The Writing Cure — How Expressive Writing Promotes Health and Emotional Well-being, Lepore SJ, Smyth JM (eds). American Psychological Association: Washington, DC, 2002; 31-52.
  • 39
    Sloan DM, Marx BP, Epstein EM. Further examination of the exposure model underlying the efficacy of written emotional disclosure. J Consult Clin Psychol 2005;73(3):549-554.
  • 40
    Wong YJ, Rochlen AB. Potential benefits of expressive writing for male college students with varying degrees of restrictive emotionality. Psychol. Men Masc. 2012;10(2):149-159.
  • 41
    Guastella AJ, Dadds MR. Cognitive–behavioural emotion writing tasks: a controlled trial of multiple processes. J Behav Ther Exp Psychiatry 2008;39(4):558-556.